PMI has well-defined goals and a set of indicators for monitoring and evaluation. Nationwide coverage of programs is monitored by collecting information through established large-scale, population-based household surveys, such as the Demographic and Health Survey (DHS), Multiple Indicator Cluster Survey (MICS), or the stand-alone Malaria Indicator Survey (MIS) which is based on the malaria module of the DHS and MICS survey instruments. These surveys enable PMI to collect information from participating countries and local regions on the proportion of:
- Pregnant women who have received two or more doses of sulfacoxine-pyrimethamine (SP) or other recommended drugs for IPT during their pregnancy
- Households with at least one ITN
- Children under 5 years of age who slept under an ITN the previous night
- Pregnant women who slept under an ITN the previous night
- Houses in areas targeted for IRS that have been sprayed
- Pregnant women and children under 5 years of age protected by either IRS or ITNs
- Children under 5 years of age with suspected malaria that have received treatment with an anti-malarial drug in accordance with national malaria treatment policies within 24 hours of the onset of their symptoms.
In addition, PMI evaluates three major aspects of malaria control operations within funded countries: (1) coverage rates for the four key interventions; (2) malaria mortality; and (3) associated factors that may affect the interpretation of these data (such as contextual information that could also influence coverage rates or mortality). PMI reports evidence from at least four of its focus countries that shows reductions in malaria transmission.